SG11202001754RA - Single immunoglobulin interleukin-1 receptor related (sigirr) variants and uses thereof - Google Patents

Single immunoglobulin interleukin-1 receptor related (sigirr) variants and uses thereof

Info

Publication number
SG11202001754RA
SG11202001754RA SG11202001754RA SG11202001754RA SG11202001754RA SG 11202001754R A SG11202001754R A SG 11202001754RA SG 11202001754R A SG11202001754R A SG 11202001754RA SG 11202001754R A SG11202001754R A SG 11202001754RA SG 11202001754R A SG11202001754R A SG 11202001754RA
Authority
SG
Singapore
Prior art keywords
sigirr
variants
receptor related
single immunoglobulin
interleukin
Prior art date
Application number
SG11202001754RA
Other languages
English (en)
Inventor
Claudia G Gonzaga-Jauregui
Julie Horowitz
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of SG11202001754RA publication Critical patent/SG11202001754RA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/06Gastro-intestinal diseases
    • G01N2800/065Bowel diseases, e.g. Crohn, ulcerative colitis, IBS

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SG11202001754RA 2017-09-06 2018-09-05 Single immunoglobulin interleukin-1 receptor related (sigirr) variants and uses thereof SG11202001754RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762554857P 2017-09-06 2017-09-06
PCT/US2018/049478 WO2019050899A1 (en) 2017-09-06 2018-09-05 SINGLE IMMUNOGLOBULIN INTERLEUKIN 1 (SIGIRR) RELATED INTERCEPTOR-RELATED VARIANTS AND USES THEREOF

Publications (1)

Publication Number Publication Date
SG11202001754RA true SG11202001754RA (en) 2020-03-30

Family

ID=63708447

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202001754RA SG11202001754RA (en) 2017-09-06 2018-09-05 Single immunoglobulin interleukin-1 receptor related (sigirr) variants and uses thereof

Country Status (11)

Country Link
US (1) US20210071251A1 (zh)
EP (1) EP3679158A1 (zh)
JP (1) JP7237064B2 (zh)
KR (1) KR20200058435A (zh)
CN (1) CN111373053A (zh)
AU (1) AU2018328120A1 (zh)
CA (1) CA3074652A1 (zh)
IL (1) IL272940B2 (zh)
MX (1) MX2020002643A (zh)
SG (1) SG11202001754RA (zh)
WO (1) WO2019050899A1 (zh)

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4634665A (en) 1980-02-25 1987-01-06 The Trustees Of Columbia University In The City Of New York Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US5179017A (en) 1980-02-25 1993-01-12 The Trustees Of Columbia University In The City Of New York Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4751180A (en) 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US4935233A (en) 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
US5294533A (en) 1988-07-05 1994-03-15 Baylor College Of Medicine Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria
US5135917A (en) 1990-07-12 1992-08-04 Nova Pharmaceutical Corporation Interleukin receptor expression inhibiting antisense oligonucleotides
US5271941A (en) 1990-11-02 1993-12-21 Cho Chung Yoon S Antisense oligonucleotides of human regulatory subunit RI.sub.α of cAMP-dependent protein kinases
US5786138A (en) 1993-01-29 1998-07-28 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Hyperstabilizing antisense nucleic acid binding agents
ATE196313T1 (de) 1993-06-04 2000-09-15 Us Health Verfahren zur behandlung von kaposi-sarcoma mit antisense-oligonukleotide
US5578716A (en) 1993-12-01 1996-11-26 Mcgill University DNA methyltransferase antisense oligonucleotides
US5641754A (en) 1994-01-10 1997-06-24 The Board Of Regents Of The University Of Nebraska Antisense oligonucleotide compositions for selectively killing cancer cells
WO1996005298A1 (en) 1994-08-09 1996-02-22 Ciba-Geigy Ag Antitumor antisense oligonucleotides
US5856103A (en) 1994-10-07 1999-01-05 Board Of Regents The University Of Texas Method for selectively ranking sequences for antisense targeting
US5994320A (en) 1995-02-06 1999-11-30 Regents Of The University Of Minnesota Antisense oligonucleotides and methods for treating central nervous system tumors
IT1275862B1 (it) 1995-03-03 1997-10-24 Consiglio Nazionale Ricerche Trascritto antisenso associato ad alcuni tipi di cellule tumorali ed oligodeossinucleotidi sintetici utili nella diagnosi e nel trattamento
US6040296A (en) 1995-06-07 2000-03-21 East Carolina University Specific antisense oligonucleotide composition & method for treatment of disorders associated with bronchoconstriction and lung inflammation
AU7286696A (en) 1995-10-13 1997-05-07 F. Hoffmann-La Roche Ag Antisense oligomers
KR19990071523A (ko) 1995-11-21 1999-09-27 해리 에이. 루스제 Il-8 및 il-8 수용체에 대한 안티센스올리고누클레오티드에 의한 종양 성장의 억제방법
CA2246503A1 (en) 1996-02-15 1997-08-21 National Institutes Of Health Rnase l activators and antisense oligonucleotides effective to treat rsv infections
US5955590A (en) 1996-07-15 1999-09-21 Worcester Foundation For Biomedical Research Conjugates of minor groove DNA binders with antisense oligonucleotides
US6046004A (en) 1997-02-27 2000-04-04 Lorne Park Research, Inc. Solution hybridization of nucleic acids with antisense probes having modified backbones
JPH1142091A (ja) 1997-07-25 1999-02-16 Toagosei Co Ltd アンチセンス核酸化合物
CA2248762A1 (en) 1997-10-22 1999-04-22 University Technologies International, Inc. Antisense oligodeoxynucleotides regulating expression of tnf-.alpha.
AU755391B2 (en) * 1997-12-23 2002-12-12 Immunex Corporation SIGIRR DNA and polypeptides
US6007995A (en) 1998-06-26 1999-12-28 Isis Pharmaceuticals Inc. Antisense inhibition of TNFR1 expression
US6013522A (en) 1999-02-23 2000-01-11 Isis Pharmaceuticals Inc. Antisense inhibition of human Smad1 expression
US6025198A (en) 1999-06-25 2000-02-15 Isis Pharmaceuticals Inc. Antisense modulation of Ship-2 expression
US6033910A (en) 1999-07-19 2000-03-07 Isis Pharmaceuticals Inc. Antisense inhibition of MAP kinase kinase 6 expression
DK3401400T3 (da) 2012-05-25 2019-06-03 Univ California Fremgangsmåder og sammensætninger til rna-styret mål-dna-modifikation og til rna-styret transskriptionsmodulering
JP6620018B2 (ja) 2012-12-06 2019-12-11 シグマ−アルドリッチ・カンパニー・リミテッド・ライアビリティ・カンパニーSigma−Aldrich Co., LLC Crisprに基づくゲノム修飾および制御
JP2019527229A (ja) 2016-07-28 2019-09-26 リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. Gpr156変異体及びその使用

Also Published As

Publication number Publication date
KR20200058435A (ko) 2020-05-27
AU2018328120A1 (en) 2020-03-19
US20210071251A1 (en) 2021-03-11
IL272940A (en) 2020-04-30
RU2020112474A3 (zh) 2021-12-29
IL272940B1 (en) 2024-02-01
IL272940B2 (en) 2024-06-01
JP2020537495A (ja) 2020-12-24
WO2019050899A1 (en) 2019-03-14
CA3074652A1 (en) 2019-03-14
CN111373053A (zh) 2020-07-03
MX2020002643A (es) 2020-09-25
EP3679158A1 (en) 2020-07-15
RU2020112474A (ru) 2021-10-06
JP7237064B2 (ja) 2023-03-10

Similar Documents

Publication Publication Date Title
IL274921A (en) BCMA-directed chimeric antigen receptor and uses thereof
IL263214A (en) Glucocorticoid receptor agonist and immune conjugates
IL280718A (en) T cell structures and their uses
HK1252009A1 (zh) 針對白細胞介素36受體(il-36r)的抗體
IL276950A (en) Anti-CD73 antibodies and uses thereof
IL282968A (en) Anti-NKG2A antibodies and their use
IL247459B (en) Antibodies against human interleukin-1 receptor auxiliary protein and their uses
ZA202002966B (en) T-cell receptor (tcr)-binding antibodies and uses thereof
EP3573104A4 (en) LIGHT RECEIVING ELEMENT, IMAGING ELEMENT AND IMAGING DEVICE
ZA202003325B (en) Glucocorticoid receptor agonist and immunoconjugates thereof
IL276746A (en) Kir3dl3 as hhla2 receptor, anti-hhla2 antibodies and their uses
IL275826A (en) Anti-mct1 antibodies and their uses
IL281297A (en) Anti-NPR1 antibodies and uses thereof
ZA201906954B (en) Btla agonist antibodies and uses thereof
IL277330A (en) Anti-IL-27 antibodies and uses thereof
IL280321A (en) Antibodies against CXCR2 and their uses
IL283875A (en) Anti-il-27 antibodies and uses thereof
IL281202A (en) Anti-TNFRSF9 antibodies and uses thereof
IL277075A (en) Anti-PHF-tau antibodies and uses thereof
IL276548A (en) Binding antibodies - BCMA and their uses
IL283926A (en) Antibodies against alpha-synuclein and their uses
IL283890A (en) Anti-periostin antibodies and their uses
GB202015416D0 (en) Chimeric antigen receptor and application thereof
IL272940A (en) Single-immunoglobulin interleukin-1 receptor-related variants and their uses
IL279790A (en) Anti-L1CAM antibodies and uses thereof